Drug:
Reaction: SEIZURE
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26928870 |
53 | 1 | |
Eye movement disorder, Salivary hypersecretion, Unresponsive to stimuli, Cardio-respiratory arrest, Tremor, Erythema, Dyspnoea, Seizure, Anaphylactic reaction, Drug hypersensitivity, Drug resistance, Catheter site discomfort, Sepsis, Escherichia infection, Urinary retention, Neurogenic bladder, |
||||
CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
| 102 | 26930310 |
42 | 2 | |
Seizure, |
||||
RISANKIZUMAB-RZAA, |
||||
| 103 | 26914690 |
US |
32 | 1 |
Seizure, Product dose omission issue, Fall, |
||||
OMAVELOXOLONE, |
||||
| 104 | 26915049 |
JP |
8 | 1 |
Seizure, Loss of consciousness, Musculoskeletal stiffness, Infusion related reaction, |
||||
NIVOLUMAB, |
||||
| 105 | 26915336 |
US |
35 | 2 |
Seizure, Road traffic accident, Product use issue, Inappropriate schedule of product administration, Therapy interrupted, |
||||
ESLICARBAZEPINE ACETATE, |
||||
| 106 | 26915409 |
52 | 2 | |
Anticholinergic syndrome, Laryngeal oedema, Loss of consciousness, Encephalopathy, Drug interaction, Toxicity to various agents, Drug level increased, Coma, Seizure, |
||||
CARBAMAZEPINE, CARBAMAZEPINE, PERAMPANEL, PERAMPANEL, CENOBAMATE, CENOBAMATE, |
||||
| 107 | 26915655 |
GB |
39 | 2 |
Seizure, |
||||
GABAPENTIN, |
||||
| 108 | 26915673 |
US |
2 | |
Seizure, Off label use, |
||||
STIRIPENTOL, CANNABIDIOL, GUANFACINE, GUANFACINE HYDROCHLORIDE, GAUNFACINE, CLONAZEPAM, |
||||
| 109 | 26915719 |
BR |
2 | |
Vulvovaginal injury, Spinal fracture, Vein rupture, Metastases to bone, Metastases to spine, Metastases to liver, Metastasis, Haemorrhage, Hydronephrosis, Urinary retention, Seizure, Breast cancer, Malignant neoplasm progression, Nail cuticle fissure, Epistaxis, Dry skin, Dry mouth, Constipation, Vulvovaginal dryness, Drug ineffective, Petechiae, Skin tightness, Visual impairment, Skin fissures, Skin atrophy, Dry throat, Nasal mucosal disorder, Rhinalgia, Secretion discharge, Insomnia, Throat irritation, Hair texture abnormal, Skin exfoliation, Breast disorder, Tumour marker increased, Calcification metastatic, Weight increased, Flatulence, Reflux gastritis, Hiatus hernia, Gastritis, Muscle spasms, Vitamin B12 deficiency, Feeding disorder, Balance disorder, Head injury, Fall, Dermal absorption impaired, Thermal burn, Nasal congestion, Eye swelling, Phlebitis, Rhinitis allergic, Allergic sinusitis, Decreased immune responsiveness, Gastric polyps, Skeletal injury, Pelvic bone injury, Epistaxis, Oropharyngeal discomfort, Hypersensitivity, Discomfort, Quality of life decreased, Rectocele, Bone lesion, Product distribution issue, Thinking abnormal, Feeling abnormal, Carbohydrate antigen 15-3 increased, PIK3CA-activated mutation, Quality of life decreased, Feeding disorder, Sensory disturbance, Skin discolouration, COVID-19, Bone pain, Condition aggravated, Anosmia, Malaise, Gene mutation, Urinary tract infection, Oral pain, Muscle injury, Hepatic mass, Dysbiosis, Oral disorder, Speech disorder, Chills, Lip swelling, Gait disturbance, Gastrointestinal disorder, Pain, Depressed mood, Myalgia, Atrophic vulvovaginitis, Nasal disorder, Head injury, Malaise, Tumour marker abnormal, Central nervous system lesion, Hepatic lesion, Cervix disorder, Uterine leiomyoma, Bacteriuria, Swelling face, Pruritus, Erythema, White blood cell count decreased, Nausea, Peripheral swelling, Vomiting, Diarrhoea, Nasopharyngitis, Dizziness, Abdominal pain upper, Cough, Retching, Fatigue, Sinusitis, Infection, Rhinitis, Abdominal pain, Dyspnoea, Abdominal discomfort, Drug resistance, Pain, Pain in extremity, Head discomfort, Decreased appetite, Vision blurred, Illness, Weight decreased, Arthralgia, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, PANTOPRAZOLE, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ALPELISIB, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, EXEMESTANE, CLONAZEPAM, CAPECITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, ERGOCALCIFEROL, |
||||
| 110 | 26915742 |
EU |
15 | 2 |
Seizure, Syncope, |
||||
| 111 | 26915751 |
US |
2 | |
Vomiting, Seizure, Diarrhoea, Alopecia, |
||||
STIRIPENTOL, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, CLONIDINE, DIVALPROEX SODIUM, DIAZEPAM, CLONAZEPAM, NORETHINDRONE, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, MELATONIN, BACITRACIN, BACITRACIN ZINC, FOLIC ACID, MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), CLOBAZAM, DICLOFENAC SODIUM, ESCITALOPRAM, ETANERCEPT, |
||||
| 112 | 26915948 |
|||
Seizure, Encephalitis autoimmune, Migraine, Nausea, Amnesia, Feeling abnormal, Vitamin B12 deficiency, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TOPIRAMATE, |
||||
| 113 | 26916486 |
US |
41 | 1 |
Seizure, Lung neoplasm malignant, Brain neoplasm malignant, Cerebrovascular accident, |
||||
ALECTINIB HYDROCHLORIDE, ALECTINIB HYDROCHLORIDE, |
||||
| 114 | 26916508 |
US |
1 | |
Seizure, Drug effect less than expected, |
||||
SODIUM OXYBATE, |
||||
| 115 | 26916615 |
CN |
||
Rash, Seizure, Urinary retention, Hot flush, Fatigue, Anaemia, Weight increased, Asthenia, Hypertension, Pruritus, Bone pain, Back pain, Constipation, Blood alkaline phosphatase increased, Arthralgia, Pain in extremity, Fall, |
||||
APALUTAMIDE, |
||||
| 116 | 26916691 |
US |
15 | 2 |
Cardiac arrest, Toxicity to various agents, Seizure, Tachycardia, Tachycardia, Agitation, Hypotension, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 117 | 26916986 |
US |
16 | 1 |
Off label use, Seizure, |
||||
STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, CLOBAZAM, CANNABIDIOL, |
||||
| 118 | 26917064 |
US |
38 | 2 |
Seizure, |
||||
RISANKIZUMAB-RZAA, |
||||
| 119 | 26917565 |
CA |
43 | 1 |
Seizure, |
||||
RITUXIMAB-PVVR, RITUXIMAB-PVVR, |
||||
| 120 | 26917767 |
US |
2 | |
Seizure, |
||||
ILOPERIDONE, |
||||
| 121 | 26917867 |
IN |
49 | 2 |
Nausea, Pain, Weight decreased, Skin hyperpigmentation, Ageusia, Fatigue, Alopecia, Skin discolouration, Insomnia, Nail discolouration, Diarrhoea, Asthenia, Peripheral swelling, Myalgia, Haemoglobin decreased, Sleep disorder, Decreased appetite, Arthralgia, Pain in extremity, Blood glucose increased, Pallor, Emotional distress, Mastectomy, Weight decreased, Loss of consciousness, Sleep disorder, Seizure, Dizziness, Oropharyngeal pain, Neck pain, Skin exfoliation, Skin irritation, Post procedural complication circulatory, Insomnia, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, |
||||
| 122 | 26917937 |
CO |
9 | 2 |
Seizure, Sleep apnoea syndrome, Inappropriate schedule of product administration, Overdose, |
||||
LACOSAMIDE, LACOSAMIDE, LEVETIRACETAM, VIGABATRIN, TOPIRAMATE, CLOBAZAM, |
||||
| 123 | 26918144 |
EU |
23 | 2 |
Coma, Seizure, Drug abuse, Vomiting, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, |
||||
| 124 | 26918160 |
CO |
75 | 1 |
Renal mass, Seizure, |
||||
EVOLOCUMAB, |
||||
| 125 | 26918410 |
US |
50 | 1 |
Pulmonary thrombosis, Coma, Seizure, Drug interaction, |
||||
DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, ALPRAZOLAM, |
||||
| 126 | 26918790 |
EU |
32 | 2 |
Seizure, Eclampsia, Local anaesthetic systemic toxicity, |
||||
| 127 | 26919295 |
US |
66 | 1 |
Seizure, Diplopia, Muscular weakness, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 128 | 26920247 |
US |
45 | 2 |
Seizure, Loss of consciousness, Fatigue, |
||||
VORASIDENIB, |
||||
| 129 | 26920399 |
US |
1 | |
Seizure, Drug ineffective, |
||||
FENFLURAMINE, FENFLURAMINE, FAMOTIDINE, BRIVARACETAM, |
||||
| 130 | 26920964 |
US |
2 | |
Seizure, |
||||
ILOPERIDONE, |
||||
| 131 | 26921147 |
CN |
31 | 1 |
Coma, Seizure, White matter lesion, |
||||
ZANUBRUTINIB, |
||||
| 132 | 26921159 |
US |
74 | 2 |
Cerebrovascular accident, Blood disorder, Gastrooesophageal reflux disease, Platelet count decreased, Vitamin D deficiency, Investigation abnormal, White blood cell count decreased, Back pain, Joint swelling, Contusion, Irritable bowel syndrome, Limb injury, Seizure, Headache, |
||||
IBRUTINIB, |
||||
| 133 | 26923878 |
74 | 2 | |
Seizure, |
||||
CENOBAMATE, |
||||
| 134 | 26909621 |
AU |
62 | 1 |
Seizure, Abdominal pain lower, Discoloured vomit, Diplopia, |
||||
BEVACIZUMAB, PANTOPRAZOLE, ENOXAPARIN SODIUM, |
||||
| 135 | 26909897 |
US |
14 | 1 |
Seizure, Heart rate increased, Pyrexia, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 136 | 26909982 |
EU |
34 | 2 |
Muscular weakness, Vomiting, Seizure, Activities of daily living decreased, |
||||
OFATUMUMAB, |
||||
| 137 | 26910471 |
4 | 2 | |
Neuropathy peripheral, Seizure, Drug effect less than expected, Malnutrition, Mucosal inflammation, Off label use, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DOXORUBICIN, ETOPOSIDE, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, PEGASPARGASE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYTARABINE, CYTARABINE, CYTARABINE, MERCAPTOPURINE, DASATINIB, BLINATUMOMAB, BLINATUMOMAB, RUXOLITINIB, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CLOFARABINE, VORINOSTAT, NELARABINE, THIOGUANINE, CALASPARGASE PEGOL, INOTUZUMAB OZOGAMICIN, INOTUZUMAB OZOGAMICIN, INOTUZUMAB OZOGAMICIN, INOTUZUMAB OZOGAMICIN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 138 | 26910504 |
GB |
17 | 2 |
Seizure, |
||||
FEXOFENADINE, FEXOFENADINE, |
||||
| 139 | 26910986 |
IN |
76 | 2 |
Off label use, Lymphadenopathy, Malaise, Seizure, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, |
||||
| 140 | 26911058 |
US |
59 | 2 |
Hip fracture, Seizure, Off label use, |
||||
DEFERIPRONE, DEFERIPRONE, DEFERIPRONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AMLODIPINE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, CINACALCET, FLUCONAZOLE, CANDESARTAN, LANTHANUM CARBONATE, SODIUM POLYSTYRENE SULFONATE, CARVEDILOL, HYDROXYZINE, ISOSORBIDE DINITRATE, PARICALCITOL, POLYETHYLENE GLYCOL, ERGOCALCIFEROL, |
||||
| 141 | 26911246 |
EG |
2 | |
Pyrexia, Seizure, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, |
||||
| 142 | 26911625 |
US |
31 | 1 |
Seizure, Product use in unapproved indication, Overdose, Product dose omission issue, Vomiting, |
||||
BRIVARACETAM, BRIVARACETAM, |
||||
| 143 | 26911801 |
US |
||
Seizure, Product dose omission issue, |
||||
CENOBAMATE, CENOBAMATE, CENOBAMATE, |
||||
| 144 | 26911830 |
GB |
39 | 2 |
Seizure, |
||||
GABAPENTIN, |
||||
| 145 | 26912032 |
JP |
118 | 2 |
Seizure, Pyrexia, Tremor, Hypersensitivity, Staring, Withdrawal syndrome, Tachycardia, Agitation, Vomiting, |
||||
DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, |
||||
| 146 | 26912070 |
US |
48 | 2 |
Seizure, |
||||
TUCATINIB, |
||||
| 147 | 26912181 |
US |
2 | |
Seizure, Somnolence, |
||||
BRIVARACETAM, BRIVARACETAM, ERGOCALCIFEROL, ACETAMINOPHEN, ASPRIN, CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE, ACETAMINOPHEN, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, ACETAMINOPHEN, CAFFEINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METHIMAZOLE, RIMEGEPANT SULFATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, UBROGEPANT, |
||||
| 148 | 26912311 |
US |
57 | 2 |
Seizure, |
||||
TUCATINIB, TUCATINIB, |
||||
| 149 | 26912323 |
EU |
23 | 2 |
Coma, Seizure, Vomiting, Drug abuse, |
||||
PREGABALIN, PREGABALIN, |
||||
| 150 | 26912443 |
EU |
||
Seizure, Arthritis, Herpes virus infection, Upper respiratory tract infection, Anaemia, |
||||
SACITUZUMAB GOVITECAN, |
||||
| 151 | 26912686 |
EU |
47 | 1 |
Spinal fracture, Gait disturbance, Impaired gastric emptying, Ileus paralytic, Seizure, Multiple acyl-coenzyme A dehydrogenase deficiency, Myalgia, Muscle spasms, Muscular weakness, Muscle twitching, Nausea, Vomiting, Product label issue, |
||||
SERTRALINE HYDROCHLORIDE, |
||||
| 152 | 26913654 |
EU |
47 | 1 |
Impaired gastric emptying, Ileus paralytic, Seizure, Spinal fracture, Multiple acyl-coenzyme A dehydrogenase deficiency, Gait disturbance, Muscular weakness, Muscle spasms, Muscle twitching, Myalgia, Nausea, Vomiting, Product label issue, |
||||
SERTRALINE, |
||||
| 153 | 26914084 |
EU |
65 | 2 |
Seizure, Inappropriate antidiuretic hormone secretion, |
||||
SPIRONOLACTONE, PANTOPRAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FUROSEMIDE, ATENOLOL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEUCOVORIN CALCIUM, |
||||
| 154 | 26904701 |
1 | ||
Psychotic disorder, Schizophrenia, Suicide attempt, Hallucination, auditory, Hallucination, visual, Seizure, Confusional state, Catatonia, Influenza, Diarrhoea, Insomnia, |
||||
MONTELUKAST SODIUM, |
||||
| 155 | 26904732 |
US |
8 | 2 |
Seizure, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, CLOBAZAM, |
||||
| 156 | 26904942 |
US |
12 | 2 |
Seizure, Tongue discolouration, |
||||
SECUKINUMAB, SECUKINUMAB, |
||||
| 157 | 26905741 |
US |
2 | |
Seizure, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 158 | 26906161 |
IN |
80 | 1 |
Seizure, Asthenia, Depressed mood, Decreased appetite, Abdominal distension, Ageusia, Restlessness, Paraesthesia, Pain in extremity, Nausea, Decreased appetite, |
||||
POLATUZUMAB VEDOTIN, |
||||
| 159 | 26906370 |
US |
82 | 2 |
Seizure, Unevaluable event, General physical health deterioration, Hypophagia, Hypersomnia, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, AMANTADINE, PIOGLITAZONE, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SITAGLIPTIN, GLIPIZIDE, |
||||
| 160 | 26906801 |
US |
67 | 2 |
Seizure, |
||||
BRIVARACETAM, |
||||
| 161 | 26907420 |
EU |
47 | 1 |
Impaired gastric emptying, Ileus paralytic, Spinal fracture, Multiple acyl-coenzyme A dehydrogenase deficiency, Gait disturbance, Seizure, Muscle spasms, Myalgia, Muscular weakness, Muscle twitching, Nausea, Vomiting, Product label issue, |
||||
SERTRALINE, |
||||
| 162 | 26907424 |
US |
51 | |
Seizure, Somnolence, |
||||
DIAZEPAM, DIAZEPAM, DIAZEPAM, DIAZEPAM, LEVETIRACETAM, |
||||
| 163 | 26908467 |
US |
50 | 1 |
Seizure, |
||||
BRIVARACETAM, |
||||
| 164 | 26908650 |
US |
1 | |
Seizure, Product use issue, Overdose, Product use in unapproved indication, |
||||
BRIVARACETAM, BRIVARACETAM, |
||||
| 165 | 26908748 |
GH |
90 | 1 |
Respiratory depression, Mental status changes, Hypoglycaemia, Bradycardia, Seizure, Hypotension, Toxicity to various agents, |
||||
CARVEDILOL, LISINOPRIL, SPIRONOLACTONE, FUROSEMIDE, |
||||
| 166 | 26908925 |
US |
39 | |
Seizure, Tibia fracture, Product dose omission issue, |
||||
CENOBAMATE, CENOBAMATE, |
||||
| 167 | 26912052 |
41 | 2 | |
Autoinflammatory disease, Constipation, Myalgia, Loss of consciousness, Aura, Seizure, Dizziness, Hyperhidrosis, Oral herpes, Ophthalmic migraine, Photophobia, |
||||
ONABOTULINUMTOXINA, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, VITAMIN C, |
||||
| 168 | 26904196 |
EU |
10 | 1 |
Seizure, Decreased appetite, Tremor, |
||||
FENFLURAMINE, |
||||
| 169 | 26904407 |
GB |
57 | 1 |
Seizure, Brain injury, Fatigue, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, |
||||
| 170 | 26902713 |
AU |
||
Seizure, |
||||
ADALIMUMAB, |
||||
| 171 | 26902904 |
US |
2 | |
Seizure, Tremor, |
||||
UBROGEPANT, |
||||
| 172 | 26903405 |
CN |
50 | 1 |
Aphasia, Cognitive disorder, Seizure, Drug intolerance, |
||||
TEMOZOLOMIDE, IMATINIB, |
||||
| 173 | 26903628 |
US |
1 | |
Seizure, Weight increased, |
||||
FENFLURAMINE, |
||||
| 174 | 26917400 |
52 | 2 | |
Seizure, Anxiety, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 175 | 26897615 |
JP |
1 | |
Seizure, |
||||
ONABOTULINUMTOXINA, |
||||
| 176 | 26897648 |
EU |
8 | 2 |
Seizure, Paroxysmal choreoathetosis, Muscle spasms, Excessive eye blinking, Stereotypy, Atrophy, Condition aggravated, Salivary hypersecretion, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, TOPIRAMATE, VALPROIC ACID, PHENYTOIN, CLOBAZAM, CLORAZEPATE DIPOTASSIUM, PHENOBARBITAL, |
||||
| 177 | 26897651 |
US |
2 | |
Seizure, |
||||
TROFINETIDE, |
||||
| 178 | 26897677 |
US |
78 | 2 |
Transient ischaemic attack, Seizure, Arthralgia, Asthenia, Joint swelling, Mobility decreased, Product dose omission issue, |
||||
OLAPARIB, OLAPARIB, |
||||
| 179 | 26898019 |
55 | 1 | |
Seizure, |
||||
TOLVAPTAN, |
||||
| 180 | 26898086 |
76 | 2 | |
Seizure, |
||||
LOSARTAN POTASSIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FUROSEMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SPIRONOLACTONE, MEGESTROL ACETATE, DONEPEZIL HYDROCHLORIDE, LACTULOSE, TRAMADOL HYDROCHLORIDE, FAMOTIDINE, DIGOXIN, GABAPENTIN, RISPERIDONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, HUMAN IMMUNOGLOBULIN G, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACYCLOVIR, CHLORPHENIRAMINE MALEATE, TORSEMIDE, ESOMEPRAZOLE SODIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CANDESARTAN CILEXETIL, BISOPROLOL FUMARATE, |
||||
| 181 | 26898289 |
US |
73 | 1 |
Seizure, |
||||
MIDAZOLAM, BRIVARACETAM, |
||||
| 182 | 26898586 |
EU |
8 | 2 |
Paroxysmal choreoathetosis, Muscle spasms, Excessive eye blinking, Stereotypy, Seizure, Atrophy, Condition aggravated, Salivary hypersecretion, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, TOPIRAMATE, VALPROIC ACID, PHENYTOIN, CLOBAZAM, CLORAZEPATE DIPOTASSIUM, PHENOBARBITAL, |
||||
| 183 | 26898675 |
US |
||
Seizure, Facial asymmetry, Therapeutic product effect incomplete, |
||||
ONABOTULINUMTOXINA, |
||||
| 184 | 26898731 |
US |
1 | |
Seizure, |
||||
DUPILUMAB, |
||||
| 185 | 26899384 |
US |
68 | 2 |
Mallory-Weiss syndrome, Shock haemorrhagic, Haemoglobin decreased, Seizure, Platelet count decreased, |
||||
CLOPIDOGREL, CLOPIDOGREL BISULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 186 | 26899563 |
CN |
18 | 1 |
Intentional overdose, Cardiac arrest, Toxicity to various agents, Seizure, Metabolic acidosis, Respiratory acidosis, Coma, Cardioactive drug level above therapeutic, Shock, Pulseless electrical activity, |
||||
AMLODIPINE, NIFEDIPINE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 187 | 26899928 |
US |
53 | 2 |
Seizure, Vulvovaginal mycotic infection, Groin infection, Palpitations, |
||||
BIMEKIZUMAB, FLUCONAZOLE, |
||||
| 188 | 26900020 |
US |
8 | |
Seizure, Product use in unapproved indication, |
||||
IPRATROPIUM BROMIDE, BACLOFEN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CLONAZEPAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, TOBRAMYCIN, TOBRAMYCIN SOLUTION, TOBRAMYCIN SULFATE, |
||||
| 189 | 26900116 |
TR |
1 | |
Seizure, |
||||
| 190 | 26900183 |
GB |
17 | 2 |
Seizure, |
||||
FEXOFENADINE, |
||||
| 191 | 26900453 |
EU |
34 | 2 |
Seizure, Malignant neoplasm progression, Decreased immune responsiveness, Malaise, Arthralgia, Gastrointestinal pain, Weight decreased, Diarrhoea, |
||||
LETROZOLE, LETROZOLE TABLETS, ABEMACICLIB, ABEMACICLIB, GOSERELIN, |
||||
| 192 | 26900515 |
US |
0 | 1 |
Seizure, Product administered to patient of inappropriate age, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, |
||||
| 193 | 26901035 |
16 | 1 | |
Brugada syndrome, Generalised tonic-clonic seizure, Overdose, Tachycardia, Hypotension, Seizure, Nausea, Vomiting, Mydriasis, |
||||
BUPROPION HYDROCHLORIDE, ALPRAZOLAM, |
||||
| 194 | 26901808 |
US |
2 | |
Seizure, Catatonia, Mitral valve thickening, Aortic valve thickening, |
||||
FENFLURAMINE, FENFLURAMINE, |
||||
| 195 | 26901923 |
US |
55 | 2 |
Seizure, Flushing, Hot flush, Rash, Respiratory disorder, Bronchitis, Pruritus, Arthralgia, Constipation, |
||||
DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, BUPROPION HYDROCHLORIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 196 | 26902450 |
CN |
74 | 2 |
Gastrointestinal haemorrhage, Seizure, Temperature intolerance, |
||||
TERIPARATIDE, CELECOXIB, CALCIUM, |
||||
| 197 | 26902458 |
CH |
63 | 1 |
Hallucination, Parkinsonism, Seizure, Dysphagia, Dysarthria, Balance disorder, Tremor, Camptocormia, Reduced facial expression, Saccadic eye movement disorder, |
||||
LORAZEPAM, OLANZAPINE, OLANZAPINE, |
||||
| 198 | 26902516 |
US |
18 | 2 |
Seizure, Product use in unapproved indication, Drug ineffective, |
||||
BRIVARACETAM, |
||||
| 199 | 26907339 |
|||
Seizure, Treatment failure, |
||||
LEVETIRACETAM, |
||||
| 200 | 26892103 |
|||
Seizure, |
||||
CARBAMAZEPINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30